Doroin, Anachel T.
HRN: 23-57-14 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/07/2023
CO-AMOXICLAV 625MG (TAB)
09/07/2023
09/13/2023
ORAL
625mg
BID
Nsvd
Waiting Final Action